Merck Announces FDA Acknowledgement of Resubmission of New Drug Application for Ezetimibe/Atorvastatin Tablets

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Jan 2, 2013 - Merck
(NYSE: MRK), known as MSD outside the United States and Canada,
announced today that the U.S. Food and Drug Administration (FDA)
has acknowledged the resubmission of a New Drug...

Source: Drugs.com - New Drug Applications - January 3, 2013 Category: Drugs & Pharmacology Source Type: news